Note 4 - Related Party Transactions

12 Months Ended

Dec. 31, 2018

Notes to Financial Statements

Related Party Transactions Disclosure [Text Block]

4. Related party transactions

In addition to transactions disclosed elsewhere in the consolidated financial statements, the related party transactions for the years presented were as follows:

Dr. Lan Huang

Dr. Lan Huang provided consulting services to BeyondSpring US at a fee of

$75,

nil

and

nil

for the years ended

December 31, 2016,

2017

and

2018

respectively.

Wanchun Biotech as a noncontrolling shareholder

On

November 28, 2016

and

January 13, 2017,

Wanchunbulin entered into purchase contracts with Wanchun Biotech to purchase drugs from Wanchun Biotech for clinical research purpose. During the years ended

December 31, 2016,

2017,

and

2018,

Wanchun Biotech purchased drugs amounting to

$110

(

RMB754

),

$547

(

RMB3,770

) and

nil

from

third

party vendors and sold to Wanchunbulin without any margin, respectively.

Dr. Ramon Mohanlal, the Chief Medical Officer

In

December 2018,

the Company provided an interest-free loan amounting to

$481

to Dr. Ramon Mohanlal which was fully repaid in

April 2019.